A detailed history of Ti Trust, Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Ti Trust, Inc holds 1,830 shares of ABBV stock, worth $322,446. This represents 0.26% of its overall portfolio holdings.

Number of Shares
1,830
Previous 1,835 0.27%
Holding current value
$322,446
Previous $314,000 14.97%
% of portfolio
0.26%
Previous 0.24%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$163.84 - $199.33 $819 - $996
-5 Reduced 0.27%
1,830 $361,000
Q2 2024

Jul 26, 2024

BUY
$154.79 - $180.76 $23,218 - $27,114
150 Added 8.9%
1,835 $314,000
Q1 2024

Apr 25, 2024

BUY
$159.82 - $182.1 $269,296 - $306,838
1,685 New
1,685 $306,000
Q3 2023

Oct 13, 2023

BUY
$133.59 - $154.65 $183,151 - $212,025
1,371 New
1,371 $204,000
Q4 2022

Feb 08, 2023

BUY
$138.31 - $165.87 $189,623 - $227,407
1,371 New
1,371 $221,000
Q4 2019

Feb 07, 2020

BUY
$72.13 - $90.25 $70,326 - $87,993
975 New
975 $86,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $312B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ti Trust, Inc Portfolio

Follow Ti Trust, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ti Trust, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ti Trust, Inc with notifications on news.